Creatine

Publication Title: 
British Journal of Sports Medicine
Author(s): 
McCrory, P.
Publication Title: 
Journal of Neurochemistry

While there have been enormous strides in the understanding of Huntington's disease (HD) pathogenesis, treatment to slow or prevent disease progression remains elusive. We previously reported that dietary creatine supplementation significantly improves the clinical and neuropathological phenotype in transgenic HD mice lines starting at weaning, before clinical symptoms appear. We now report that creatine administration started after onset of clinical symptoms significantly extends survival in the R6/2 transgenic mouse model of HD.

Author(s): 
Dedeoglu, Alpaslan
Kubilus, James K.
Yang, Lichuan
Ferrante, Kimberly L.
Hersch, Steven M.
Beal, M. Flint
Ferrante, Robert J.
Publication Title: 
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology

There has been considerable interest in the use of creatine (Cr) supplementation to treat neurological disorders. However, in contrast to muscle physiology, there are relatively few studies of creatine supplementation in the brain. In this report, we use high-field MR (31)P and (1)H spectroscopic imaging of human brain with a 7-day protocol of oral Cr supplementation to examine its effects on cerebral energetics (phosphocreatine, PCr; ATP) and mitochondrial metabolism (N-acetyl aspartate, NAA; and Cr).

Author(s): 
Pan, J. W.
Takahashi, K.
Publication Title: 
The American Journal of Psychiatry

OBJECTIVE: Proton magnetic resonance spectroscopy ((1)H-MRS) has been increasingly used to examine striatal neurochemistry in adult major depressive disorder. This study extends the use of this modality to pediatric major depression to test the hypothesis that adolescents with major depression have elevated concentrations of striatal choline and creatine and lower concentrations of N-acetylaspartate.

Author(s): 
Gabbay, Vilma
Hess, David A.
Liu, Songtao
Babb, James S.
Klein, Rachel G.
Gonen, Oded
Publication Title: 
Epilepsy & Behavior: E&B

OBJECTIVE: The mechanism of action of levetiracetam (LEV), an antiepileptic drug, is related to a novel binding site, SV2, but LEV acts on GABA-A receptors. The objective of the study described here was to determine if LEV modulates brain GABA in vivo. METHODS: Concentrations of cerebral GABA and serum LEV were obtained in seven healthy individuals using 1H magnetic resonance spectroscopy at baseline and 3 and 6 hours following oral administration of 1 g of LEV. RESULTS: Brain cerebral GABA acutely concentrations did not change from baseline.

Author(s): 
Kuzniecky, R.
Pan, J.
Burns, A.
Devinsky, O.
Hetherington, H.
Publication Title: 
Neurology

BACKGROUND: Characterization of the behavioral correlates of neuromorphometry and neurochemistry in older adults has important implications for an improved understanding of the aging process. The objective of this study was to test the hypothesis that a measure of hippocampal neuronal metabolism was associated with verbal memory in nondemented older adults after controlling for hippocampal volume. METHODS: 4-T MRI, proton magnetic resonance spectroscopy ((1)H MRS), and neuropsychological assessment were conducted in 48 older adults (23 women; mean age 81 years).

Author(s): 
Zimmerman, M. E.
Pan, J. W.
Hetherington, H. P.
Katz, M. J.
Verghese, J.
Buschke, H.
Derby, C. A.
Lipton, R. B.
Publication Title: 
Amyotrophic Lateral Sclerosis: Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases

Our objective was to determine the effect of creatine monohydrate on disease progression in patients with amyotrophic lateral sclerosis (ALS). One hundred and seven patients with the diagnosis of probable or definite ALS, of less than five years duration from symptom onset, were randomized to either treatment with daily creatine monohydrate (5 g/d) or placebo.

Author(s): 
Rosenfeld, Jeffrey
King, Ruth M.
Jackson, Carlayne E.
Bedlack, Richard S.
Barohn, Richard J.
Dick, Arthur
Phillips, Lawrence H.
Chapin, John
Gelinas, Deborah F.
Lou, Jau-Shin
Publication Title: 
PloS One

BACKGROUND: Progressive resistance exercise training (PRT) improves physical functioning in patients with HIV infection. Creatine supplementation can augment the benefits derived from training in athletes and improve muscle function in patients with muscle wasting. The objective of this study was to determine whether creatine supplementation augments the effects of PRT on muscle strength, energetics, and body composition in HIV-infected patients.

Author(s): 
Sakkas, Giorgos K.
Mulligan, Kathleen
Dasilva, Makani
Doyle, Julie W.
Khatami, Hootan
Schleich, Thomas
Kent-Braun, Jane A.
Schambelan, Morris
Publication Title: 
Epilepsy Research

EEG power and high frequency activity in the seizure onset zone has been increasingly considered for its relationship with seizures in animal and human studies of epilepsy. We examine the relationship between quantitative EEG measures and metabolic imaging in epilepsy patients undergoing intracranial EEG (icEEG) analysis for seizure localization. Patients with mesial temporal lobe epilepsy (MTLE) and neocortical epilepsy (NE) were studied. Metabolic imaging was performed with MR spectroscopic imaging using N-acetyl aspartate (NAA) and creatine (Cr).

Author(s): 
Pan, J. W.
Zaveri, H. P.
Spencer, D. D.
Hetherington, H. P.
Spencer, S. S.
Publication Title: 
Current Opinion in Clinical Nutrition and Metabolic Care

PURPOSE OF REVIEW: Weight loss and low BMI due to an underlying illness have been associated with increased mortality, reduced functional capacity, and diminished quality of life. There is a need for well tolerated, long-term approaches to maintain body weight in patients with cachexia or wasting. The purpose of this review is to highlight the scientific and clinical evidence derived from the recent literature investigating the rationale for and potential medical use of creatine supplementation in patients with cachexia or wasting.

Author(s): 
Sakkas, Giorgos K.
Schambelan, Morris
Mulligan, Kathleen

Pages

Subscribe to RSS - Creatine